Below is a concise month-by-month overview of expected results from daily use of one Prime Biome gummy, based on its claims, ...

The formula is designed to work for people of all ages and body conditions. Relevant clinical studies and research-based ...

Paris, France (23 avril 2025 – 18h00) – EssilorLuxottica annonce un chiffre d’affaires consolidé au premier trimestre 2025 de 6 848 millions d’euros, en hausse de +7,3 % à taux de change constants 1 ...

Les abstracts des présentations seront disponibles sur le site de l’ASCO jeudi 22 mai 2025.

AB Science SA (Euronext - FR0010557264 - AB) annonce aujourd'hui que la molécule AB8939 a obtenu la désignation de médicament orphelin auprès du Comité des Médicaments Orphelins (COMP) de l’Agence ...

AB Science SA (Euronext - FR0010557264 - AB) announces today that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) granted orphan drug status to AB8939 for the ...

PHOENIX, April 23, 2025 (GLOBE NEWSWIRE) -- Advanced Medical Pricing Solutions (“AMPS”), a diversified healthcare technology company supporting transparent, affordable medical and prescription ...

Paris, France (April 23, 2025 - 6:00 pm) – EssilorLuxottica announced today that consolidated revenue for the first quarter of 2025 reached Euro 6,848 million, representing a year-on-year increase of ...

Partnered Assets: SIRPα antagonists BI 765063 and BI 770371, an improved next generation SIRPα inhibitor, developed in partnership with Boehringer Ingelheim: Rapid Oral Abstracts of the Phase 1 ...

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that it will present two poster abstracts at the ...

All shares of common stock and pre-funded warrants to be sold in the offering will be offered by Rezolute. The closing of the offering is expected to occur on or about April 24, 2025, subject to the ...

By delivering up-to-date, multimodal data, OneMedNet expands its reach into the domain of AI-ready data for healthcare intelligence. Partnering with Protege is strategically significant because the AI ...